Log in to save to my catalogue

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal canc...

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51bffec067d642f8a6e2d9a8af7b2752

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

About this item

Full title

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2018-11, Vol.9 (1), p.4672-14, Article 4672

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Oncological use of anti-angiogenic VEGF inhibitors has been limited by the lack of informative biomarkers. Previously we reported circulating Tie2 as a vascular response biomarker for bevacizumab-treated ovarian cancer patients. Using advanced MRI and circulating biomarkers we have extended these findings in metastatic colorectal cancer (
n
...

Alternative Titles

Full title

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_51bffec067d642f8a6e2d9a8af7b2752

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51bffec067d642f8a6e2d9a8af7b2752

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-07174-1

How to access this item